dc.creatorGOMEZ ORTIZ, EDNA
dc.creatorZACCHÉ, EVANDRO
dc.creatorGAVA,, FABIO N
dc.creatorCAMACHO, APARECIDO
dc.date.accessioned2014-01-03 00:00:00
dc.date.accessioned2022-06-30T15:04:09Z
dc.date.accessioned2022-09-29T12:22:07Z
dc.date.available2014-01-03 00:00:00
dc.date.available2022-06-30T15:04:09Z
dc.date.available2022-09-29T12:22:07Z
dc.date.created2014-01-03 00:00:00
dc.date.created2022-06-30T15:04:09Z
dc.date.issued2014-01-03
dc.identifierhttps://repositorio.unisucre.edu.co/handle/001/1237
dc.identifier10.24188/recia.v6.n1.2014.244
dc.identifier2027-4297
dc.identifierhttps://doi.org/10.24188/recia.v6.n1.2014.244
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3749986
dc.languagespa
dc.publisherUniversidad de Sucre
dc.relationABBOT, J. A. 2000. Chapter 34: Degenerative valvular disease. Págs. 212-213 en Aboott, J.A. (Ed.) Small Animal Cardiology Secrets. Hanley & Belfus, Inc, Philadelphia.
dc.relationATKINS, C.E., BROWN, A.W., COATS, J.R. et al. 2002. Efects of long-term administration of enalapril on clinical indicatons of renal function in dogs with compensated mitral regurgitation. Journal of the American Veterinary Medical Association 21: 654-658.
dc.relationATKINS, C.E., HAGGSTROM, J. 2012. Pharmacologic management of myxomatous mitral valve disease in dogs. Journal of Veterinary Cardiology 14: 165-184.
dc.relationBOON, J.A. 2011. Acquired heart disease. Cap 5, Págs 267-334 en: Boon JA, Manual of Veterinary Echocardiography. Baltinore: Willians y Wilkins, USA.
dc.relationBORGARELLI, M., HAGGSTROM, J. 2010. Canine degenerative myxomatous mitral valve disease: natural history, clinical presentation and therapy. Veterinary Clinics of North America: Small Animal Practice 40: 651-663.
dc.relationBORGARELLI, M., BUCHANAN, J.W. 2012. Historical review, epidemiology and natural history of degenerative mitral valve disease. Journal of Veterinary Cardiology 14: 93 -101.
dc.relationBUCHAMAN, J.W., BUCHELER, J. 1995. Vertebral scale system to measure canine Heart size in radiographs. Journal of Veterinary Internal Medicine 206: 194-199.
dc.relationBUCHAMAN, J.W. 1997. Chronic valvular disease (endocardiose) in dogs. Advances in Veterinary Science 21: 75-106.
dc.relationCALVERT, C.A. 1991. Efect of medical therapy on survival of patients with dilated cardiomyopathy. Veterinary Clinics of North America: Small Animal Practice 21: 919-930.
dc.relationCHIU, A.T., HERBLIN, W.F., MCCALL, D.E., PRICE, W.A., WONG, P.C., CARINI, D.J. et al. 1990. Angiotensin II receptor subtypes and their selective nonpeptide ligands. Receptor 1: 33-40.
dc.relationCOBB, M.A. 2000. Capítulo 12: Insuficiencia cardíaca izquierda. Págs 225-44 en Luis Fuentes, V. y SWIFT, S.T. Manual de Medicina y Cirugía Cardiorrespiratoria. Editorial Harcourt. España.
dc.relationCROZIER, I., IKRAM, H., AWAN, N. et al. 1995 Losartana in heart failure: hemodynamic effects and tolerability. Circulation 91, 691-697.
dc.relationDE MORAIS, H.A. 2000. Pathophysiology of heart failure and evaluation of cardiac function. Págs 692-712 en: Ettinger SJ, Feldman EC. Textbook of Veterinary Internal Medicine. 5º edición. Editorial Saunders. Philadelphia.
dc.relationDICKSTEIN, K., CHANG, P., WILLENHEIMER, R., HAUNSØ, S., REMES, J., HALL, C., KJEKSHUS, J. 1995. Comparison of the efectts of losartan and enalapril on clinical status and exercise performance in with moderate or severe chronic heart failure patients. Journal of the American College of Cardiology 26, Issue 2: 438–445.
dc.relationFRANCO, R.P. 2009. Avaliação clínica da utilização da furosemida, maleato de enalapril, espironolactona e suas combinações em cães com endocardiose de válvula mitral. Dissertação de mestrado – Faculdade de ciências Agrárias e Veterinárias, Universidade Estadual Paulista, Jaboticabal.
dc.relationFRANCO, R.P., CHAMPION, T., PASCON, J.P.E., NETO, G.B.P., JUNIOR, D.P., CAMACHO, A.A. 2011. Utilização do maleato de enalapril, furosemida, espironolactona e suas associações em cães com doença degenerativa mixomatosa da válvula mitral. ARS Veterinária 2: 85-93.
dc.relationHÄGGSTRÖM, J., HANSSON, K., KVART, C., KARLBERG, B.E., VUOLTEENAHO, O., OLSSON, K. 1997. Effects of naturally acquired decompensated mitral valve regurgitation on the rennin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs. American Journal of Veterinary Research, 58: 77-82.
dc.relationHAMLIN, R.L., BENITZ, A.M., ERICSSON, G.F., CIFELLI, S., DAURIO, C.P. 1996. Effects of enalapril on exercise tolerance and longevity in dogs with heart failure produced by iatrogenic mitral regurgitation. Journal of Veterinary Internal Medicine 2: 85-87.
dc.relationInternational Small Animal Cardiac Health Council (ISACHC). 1995. Recommendations for the diagnosis of heart disease and the treatment of heart failure in small animals. In: Miller MS, Tilley LP, eds. Manual of canine and feline cardiology. 2nd ed. Philadelphia: WB Saunders.
dc.relationKIENLE, R.D., THOMAS, W.P. 1995. Echocardiography. Págs.198-255 en: Nyland TG, Mattoon JS. Veterinary Diagnostic Ultrasound. 2ª ed. Editorial Saunders. Philadelphia.
dc.relationKITAGAWA, H., WAKAMIYA, H., KITOH, K. et al. 1997. Efficacy of monotherapy with benazepril, an angiotensin-converting enzyme inhibitor, in dogs with naturally acquired chronic mitral insufficiency. Journal of Veterinary Medical Science 59: 513-520.
dc.relationKITTLESON, M.D. 2006. Myxomatous atrioventricular valvular degeneration. Págs. 52 en: Kittleson MD. Textbook of Cardiovascular Medicine, 3º ed. en DVD, St Louis: Mosby DVD.
dc.relationMUCHA, C.J., CAMACHO, A.A. 2007. Afecciones Cardiovasculares en Pequeños Animales. Págs. 179-183. Segunda edición. Editorial Inter.-Medica, Buenos Aires.
dc.relationPARKER, H.G., KILROY-GLYNN, P. 2012. Myxomatous mitral valve disease in dogs: Does size matter?. Journal of Veterinary Cardiology 14: 19- 29.
dc.relationPEREIRA, J.D.G. 1996. Variações de parâmetros clínicos-laboratoriais de cães tratados com furosemida. Dissertação de mestrado – Faculdade de ciências Agrárias e Veterinárias, Universidade Estadual Paulista, Jaboticabal.
dc.relationPEREIRA, P.M., CAMACHO, A.A., MORAIS, H.A. 2005. Tratamento da insuficiência cardíaca com benazepril em cães com cardiomiopatia dilatada e endocardiose. Arquivo Brasileiro de Medicina Veterinária e Zootecnia 57: 1-6.
dc.relationPEREZ-DIAZ, I., HIRIART, M., OLIVARES-REYES, J.A., ROBLES-DIAZ, G. 2006. Receptores para la angiotensina II diferentes a los clásicos receptores membranales AT1 y AT2: Características y su papel en el funcionamiento celular. Revista de Educación Bioquímica 25: 55-60.
dc.relationREGOLI, D., PARK, W.K., RIOUX, F. 1974. Pharmacology of angiotensin. Pharmacology & Therapeutics 26: 69-123.
dc.relationRIPKEN, A., DEINERT, M. 2002. A clinical trial about efficacy of pimobendan in comparison to enalapril in dogs with mitral valve endocardiosis. Part 1: clinical, laboratory, radiologic and electrocardiographic results. DisponÌvel em www.vin.com/proceedings/proceedings.plx/cid=WSAVA.
dc.relationROTH, A.L. 1993. Use of angiotensin-converting-inhibitor in dog with congestive failure. Com Edu Rev 15: 1240-1244.
dc.relationSABRI, A., RAFIQ, K., SEQQAT, R., KOLPAKOV, M.A., DILLON, R., DELL’ITALIA, L.J. 2008. Sympathetic activation causes focal adhesión signaling alteration in early compensated volumen overload attributable to isolated mitral regurgitation in the dog. Circulation Research 102: 1127-1136.
dc.relationSEARLE, A. 1987. Vasodilatador: What they have to offer in management of congestive heart failure. Australian Veterinary Practitioner 17: 11-20.
dc.relationSILVA, M.B., ALMEIDA, A.O., FADEL, L., AMBRÓSIO, C.E., MIGLINO, M.A. 2009. Influência do bloqueador de receptor de angiotensina (Losartana potássica) na função renal e pressão arterial em cães GRMD. Pesquisa Veterinária Brasileira 29: 322-326.
dc.relationSILVA, M.B. 2009. O efeito do losartan na morfologia do músculo esquelético do modelo Golden Retriever Muscular Dystrophy: uma droga promissora para a regeneração da musculatura distrófica? Dissertação de mestrado. Faculdade de Medicina Veterinária e Zootecnia da universidade de São Paulo.
dc.relationSISSON, D. 1991. Evidence for or against the efficacy of afterload reducers for management of Herat failure in dogs. Veterinary Clinics of North America: Small Animal Practice 21: 945-955.
dc.relationSOARES, E.C., LARSSON, M.H.M.A., PINTO, A.C.B.C.F. 2004. Aspectos radiográficos na doença valvular crônica. Ciência Rural 34: 119-124.
dc.relationSOARES, E.C., LARSSON, M.H.M.A., YANATO, R.J. 2005. Chronic valvular disease: correlation between clinical, eletrocardiographic, radiographic and echocardiographic aspects in dogs. Arquivo Brasileiro de Medicina Veterinária e Zootecnia 57: 436-441.
dc.relationTILLEY, L.P. 1992. Interpretations of Q, R, S, T deflections. Págs. 59-99 en: Tilley, L.P. (Ed.). Essentials of canine and feline eletrocardiography. Tercera edición. Editorial Lea y Febiger. Phyladelphia.
dc.relationVIGOA, A.V., ALVARES, N.C., DEL VALLE, Z.G., CRUZ, A.V. 1998. Antagonistas de los receptores de angiotensina II. Revista Cubana de Medicina 37: 83-92.
dc.relationWOLF, R., CAMACHO, A.A., SOUZA, R.C.A. 2000. Eletrocardiografia computadorizada em cães. Arquivo Brasileiro de Medicina Veterinária e Zootecnia 52: 610-615.
dc.relationhttps://revistas.unisucre.edu.co/index.php/recia/article/download/244/285
dc.relationNúm. 1 , Año 2014 : RECIA 6(1):ENERO-JUNIO
dc.relation170
dc.relation1
dc.relation159
dc.relation6
dc.relationRevista Colombiana de Ciencia Animal - RECIA
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.sourcehttps://revistas.unisucre.edu.co/index.php/recia/article/view/244
dc.subjectenalapril
dc.subjectendocardiosis
dc.subjectlosartan
dc.subjectvasodilators
dc.titleLosartan versus enalapril in dogs asymptomatic carriers of myxomatous degeneration of mitral valve
dc.typeArtículo de revista
dc.typeJournal article


Este ítem pertenece a la siguiente institución